眼轮匝肌切除术治疗眼睑痉挛 2013 年版
Myectomy for blepharospasm 2013.
机构信息
Center for Facial Appearances, Salt Lake City, Utah 84102, USA.
出版信息
Curr Opin Ophthalmol. 2013 Sep;24(5):488-93. doi: 10.1097/ICU.0b013e3283645aee.
PURPOSE OF REVIEW
Botulinum toxin (BTX) injections are the main medical treatment of facial dystonias, but injections are ineffective in some patients. This review discusses the indications for myectomy and surgical technique for treating benign essential blepharospasm (BEB) and apraxia of eyelid opening (ALO).
RECENT FINDINGS
There are four reasons to consider myectomy for patients with BEB. The first is ALO associated with BEB. The second is patients with blepharospasm-associated deformities. The third is patients who are truly unresponsive to BTX. The fourth is patients who cannot afford or who refuse BTX injections.
SUMMARY
Myectomy remains essential for treating blepharospasm patients and the most common indication is those with associated ALO.
目的综述
肉毒毒素（BTX）注射是治疗面肌痉挛的主要医学手段，但在一些患者中注射无效。本综述讨论了眼肌切除术的适应证和手术技术，用于治疗良性特发性眼睑痉挛（BEB）和动眼神经不能引起的睑裂闭合不全（ALO）。
最近的发现
对于 BEB 患者，有四个考虑进行眼肌切除术的原因。第一个是与 BEB 相关的 ALO。第二个是眼睑痉挛相关畸形的患者。第三个是对 BTX 治疗无反应的真正患者。第四个是无法承担或拒绝 BTX 注射的患者。
总结
眼肌切除术仍然是治疗眼睑痉挛患者的重要手段，最常见的适应证是那些伴有 ALO 的患者。
Zotero 插件